← Back to all trials
Recruiting
NCT06820606
Comparing Rezum and Urolift
Conditions: Benign Prostatic Hyperplasia
Sex: Male
Ages: 50 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 120
Sponsor: Chinese University of Hong Kong
Location: Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong
Summary
This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or prostatic urethral lift (UroLift) arm.
Eligibility Criteria
Inclusion Criteria:
* Male ≥ 50 years Symptomatic BPH International prostate symptom score (IPSS) ≥13 Prostate volume 30-80ml
Exclusion Criteria:
* History or high suspicion of prostate cancer
* Current urinary tract infection
* Refractory urinary retention or post-void residual (PVR) ≥250 mL
* Intravesical prostatic protrusion (IPP)\>10mm
* Prior prostate surgery
* Known or suspected allergy to nickel, titanium, or polyester/polypropylene
* Urethral stricture, meatal stenosis, bladder neck contracture
* Neurogenic bladder and/or sphincter abnormalities
Source: ClinicalTrials.gov (NCT06820606). StuddyBuddy aggregates publicly available trial information.